Agenda 2022


Clinical Topics in Breast Cancer

Chaired by Erika P. Hamilton, MD

Novel SERDs and Related Compounds (SERCA, PROTAC, CERAN, SERM)
Novel Endocrine Targeted Novel Endocrine Targeted Agents (PI3, AKT, FGF)
Right Sizing Adjuvant Therapy (Genomic Risk Stratifying Assays)
Immunotherapy Considerations for Triple Negative Breast Cancer
Personalized Treatment Options for HER2
Managing Brain Metastases in Breast Cancer Patients
Novel ADCs – Saci, TDXd, dato-DXD, HER-3DXD, LIV-1 & Others

Clinical Topics in Gynecological Cancers

Chaired by Kathleen N. Moore, MD, MS

Changing Treatment Paradigms for Ovarian and Cervical Cancers
Approaches to Treating Advanced and Recurrent Disease
Therapeutic Strategies for Cervical Malignancies
First- and Second-Line Therapies in Endometrial Cancer
Molecular Profiling in Gynecological Cancers
Optimizing Outcomes for Patients Dispositioned to NACT; Is HIPEC the Savior?

Special Topics in Breast and Gynecological Cancers

Understanding Barriers to Minority Participation in Clinical Trials
Financial Toxicity, Access, and Generational Mistrust
Care for Transgender and Special Population Patients
Sexual Side Effects of Cancer and Care